Wire · opportunities
Ochsner uses AI to widen clinical trial screening
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 6 October 2026 · Fusion42 review
Ochsner Health uses AI to enhance patient screening for clinical trials, increasing screening capacity by 41%, tripling patient follow-up for future eligibility, and reducing manual screening work by 75%. The AI platform integrates with electronic health records to identify patients across a broad population and track eligibility changes over time, streamlining the clinical trial recruitment process.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
You can now expand clinical trial recruitment beyond traditional manual methods using AI tied directly to patient records, cutting screening time and tracking patient eligibility changes automatically. That opens access to trials for many patients who slipped through the cracks before and shifts how your study teams prioritise candidates.
◆ Coverage
1 source · 6 Oct 2026
◆ Related on Wire
◆ Topics